Kyongbo Pharmaceutical Co., Ltd

KRX:214390.KS

7440 (KRW) • At close March 27, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) KRW.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q2
Revenue 62,60061,267.54354,581.94552,554.19447,953.79957,812.36949,330.65446,107.15343,014.72741,943.06638,959.24946,064.70343,692.62748,542.63954,737.22860,199.45651,805.77248,605.54645,295.88352,889.47844,915.28353,070.4450,290.47950,721.54347,261.13448,531.44146,633.22451,129.67245,367.03743,850.13646,876.15151,122.71244,877.17245,728.24645,296.61843,658.96843,348.845,530.22741,129.5341,573.44
Cost of Revenue 42,892.54544,287.57838,572.01236,746.09135,256.74242,674.13139,475.15536,136.11733,561.62734,632.6532,169.46935,546.94932,950.28636,937.10241,535.37245,308.74639,039.13540,235.37136,356.19239,326.97135,071.50240,773.60538,714.05537,906.06434,688.69336,246.9431,425.4937,239.75432,126.49932,652.45837,707.20939,340.45332,922.64733,696.38333,327.61731,026.75531,424.63234,871.45129,147.08128,811.073
Gross Profit 19,707.45516,979.96516,009.93315,808.10312,697.05715,138.2389,855.4999,971.0359,453.17,310.4166,789.7810,517.75510,742.34111,605.53713,201.85614,890.7112,766.6378,370.1758,939.69113,562.5069,843.78112,296.83411,576.42412,815.47912,572.44112,284.50115,207.73413,889.91813,240.53811,197.6789,168.94211,782.25911,954.52512,031.86311,969.00112,632.21311,924.16810,658.77611,982.44912,762.367
Gross Profit Ratio 0.3150.2770.2930.3010.2650.2620.20.2160.220.1740.1740.2280.2460.2390.2410.2470.2460.1720.1970.2560.2190.2320.230.2530.2660.2530.3260.2720.2920.2550.1960.230.2660.2630.2640.2890.2750.2340.2910.307
Reseach & Development Expenses 3,740.3493,596.0752,739.6723,244.2662,805.5491,964.2412,746.6522,304.7630000000000000102.846270.734122.809273.38887.118109.859309.939258.487574.884211.831325.338372.405427.403534.078390.338514.919502.461421.235209.056
General & Administrative Expenses 17,389.073-39,415.23514,270.79114,318.65813,207.181-29,733.63510,738.54410,759.70110,149.002-29,071.49810,472.03910,757.19310,130.543-28,824.39611,092.30610,032.29110,630.322-20,481.7677,989.3538,409.6968,062.05915.177888.105842.632643.976620.79970.1991,371.1151,410.014852.9231,242.9361,116.2741,035.751958.524953.138892.026751.265946.451,002.495-865.2
Selling & Marketing Expenses -4,477.99453,568.89200000000000000000001,934.2342,164.412,009.9481,898.1882,339.3531,980.2781,848.0121,728.341,302.9541,384.1151,727.6482,010.3811,213.9331,330.6561,125.7791,500.771,454.8071,477.3891,819.106
SG&A 12,911.07914,153.65714,270.79114,318.65813,207.181-7,610.77410,738.54410,759.70110,149.002-11,917.94410,472.03910,757.19310,130.543-17,420.43811,092.30610,032.29110,630.322-11,607.0047,989.3538,409.6968,062.052,849.4113,052.5152,852.582,542.1642,960.1432,950.4773,219.1273,138.3542,155.8772,627.0512,843.9223,046.1322,172.4572,283.7942,017.8052,252.0352,401.2572,479.884953.906
Other Expenses -59,544249.863-28,541.58284.94-26,414.36218,988.74894.206-225.9951,368.438246.309158.904129.034153.138-2,430.77968.0991,648.61297.638-1,715.451666.089-166.4241,473.335105.4822.1137.19131.8451,838.42777.924161.689113.615191.654143.39240.073230.457228.24639.892310.43870.403382.635-140.3853,112.37
Operating Expenses 59,54414,153.657-14,270.79114,318.658-13,207.18111,377.97410,738.54410,759.70110,149.00210,625.36210,472.03910,757.19310,130.54312,048.38811,092.30610,032.29110,630.32210,060.9817,989.3538,409.6968,062.058,605.4268,038.0257,973.4397,377.7136,771.6867,751.5237,878.7667,634.0677,705.046,768.4897,504.7586,530.8876,209.3485,870.5735,628.345,216.656,758.2746,843.0034,117.238
Operating Income 3,0562,826.3091,739.1421,489.445-510.1243,760.264-883.045-788.665-695.902-3,314.946-3,682.259-239.438611.799-442.8512,109.554,858.4192,136.315-1,690.807950.3385,152.8111,781.7313,691.4093,538.3994,842.0395,194.7285,512.8157,456.2126,011.1515,606.4713,492.6382,400.4524,277.5015,423.6365,822.5156,098.4287,003.8746,707.5183,900.5035,139.4478,645.129
Operating Income Ratio 0.0490.0460.0320.028-0.0110.065-0.018-0.017-0.016-0.079-0.095-0.0050.014-0.0090.0390.0810.041-0.0350.0210.0970.040.070.070.0950.110.1140.160.1180.1240.080.0510.0840.1210.1270.1350.160.1550.0860.1250.208
Total Other Income Expenses Net -1,096-826.386-913.869-933.832-424.917-2,071.52153.511-567.529478.05-904.308-2,181.894-1,566.7541,344.8531,311.6391,836.671,366.402854.649-561.375627.622-509.6661,231.499263.855-380.501353.564140.055326.3096.915308.583-967.418788.267-956.754339.143-121.798-411.124571.10498.603-358.61319.321-226.1342,523.398
Income Before Tax 1,9601,999.923825.273555.613-935.0411,688.745-729.534-1,356.195-217.852-4,219.254-5,864.153-1,806.1921,956.651868.7883,946.226,224.822,990.964-2,252.1811,577.9614,643.1443,013.233,955.2643,157.8985,195.6035,334.7835,839.1257,463.1276,319.7344,639.0534,280.9051,443.6984,616.6445,301.8385,411.3916,669.5327,102.4776,348.9084,219.8244,913.31311,168.527
Income Before Tax Ratio 0.0310.0330.0150.011-0.0190.029-0.015-0.029-0.005-0.101-0.151-0.0390.0450.0180.0720.1030.058-0.0460.0350.0880.0670.0750.0630.1020.1130.120.160.1240.1020.0980.0310.090.1180.1180.1470.1630.1460.0930.1190.269
Income Tax Expense 310-311.13860.779-356.95-195.166265.411-774.859-338.493-377.485-1,132.587-1,321.848-421.807438.474532.0961,479.8671,629.276985.107-434.639130.2661,145.116856.172978.972869.4211,386.8291,292.2761,535.8471,877.8451,757.1531,126.884858.531236.729940.978900.917-4,916.4331,577.8881,405.3341,355.89715,768.877738.9482,552.704
Net Income 1,649.7412,037.218764.494912.563-739.8751,423.33345.325-1,017.701159.633-3,086.667-4,542.305-1,384.3851,518.178336.6922,466.3534,595.5442,005.857-1,817.5421,447.6953,498.0282,157.0582,976.292,288.4783,808.7744,042.5074,303.2785,585.2824,562.5813,512.1693,422.3741,206.9693,675.6654,400.92110,327.8245,091.6455,697.1424,993.012-11,549.0534,174.3658,615.823
Net Income Ratio 0.0260.0330.0140.017-0.0150.0250.001-0.0220.004-0.074-0.117-0.030.0350.0070.0450.0760.039-0.0370.0320.0660.0480.0560.0460.0750.0860.0890.120.0890.0770.0780.0260.0720.0980.2260.1120.130.115-0.2540.1010.207
EPS 69.0285.2131.9838.17-30.9559.541.9-437-130.78-190-5864-910319284-7661146901259615916918023419114714350154184442213263232-535.01194400
EPS Diluted 69.0285.2131.9838.17-30.9559.541.9-437-130.78-190-5864-910319284-7661146901259615916918023419114714350154184442213263232-535.01194400
EBITDA 3,0565,816.70916,009.9334,433.97112,697.0576,263.6331,940.4412,304.0832,483.821-2,262.448-483.278-239.438611.7999,254.4085,174.6924,858.4192,136.315395.409950.3385,152.8114,740.5536,912.1436,211.4768,248.3418,343.9268,957.64210,622.5939,438.6237,745.8897,387.1174,431.327,357.1557,825.1817,942.9938,991.5199,338.878,634.1186,703.777,110.44111,659.31
EBITDA Ratio 0.0490.0950.2930.0840.2650.1080.0390.050.058-0.054-0.012-0.0050.0140.1910.0950.0810.0410.0080.0210.0970.1060.130.1240.1630.1770.1850.2280.1850.1710.1680.0950.1440.1740.1740.1990.2140.1990.1470.1730.28